印度阿達尼集團否認與比亞迪(01211.HK)合作
日前有報道指,印度阿達尼集團(Adani Group)正與比亞迪(01211.HK)就戰略合作夥伴關係進行深入談判,以促進印度電池製造業發展,阿達尼集團強烈反駁,指有關報道「毫無根據、不準確且具誤導性」,並強調目前未有考慮或討論與比亞迪或北京衛藍新能源科技(Beijing Welion New Energy Technology)的合作。
有關報道指,阿達尼集團擬與比亞迪合作,旨在利用比亞迪的磷酸鐵鋰(LFP)及刀片電池技術,建立超級工廠與先進能源儲存解決方案。報道更指,交易可能以合資企業或技術共享協議形式進行,符合阿達尼集團進軍電動車與再生能源領域的整體佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.